LONDON (Alliance News) - Venn Life Sciences Holdings PLC Tuesday said Chairman David Evans bought 210,000 shares at a price of 20.5 pence per share.
Following this transaction, Evans now holds 289,033 shares.
Shares in the clinical trial services company were trading flat at 20.5 pence Tuesday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.